-
Altera Q3 Revenue Expectations Inline With Estimates
Monday, October 11, 2010 - 9:19am | 165Altera Corporation (NasdaqGS: ALTR) to report Q3 revenue roughly inline with street and Jefferies & Company estimates of $526MM in their mid-quarter update. In a research report Jefferies & Company writes, "We believe Altera will guide Q4 revenue flat to up 5% Q/Q, above our estimate of $...
-
Strong 3Q As China Delivers For YUM
Thursday, October 7, 2010 - 9:21am | 143Yum! Brands, Inc. (NYSE: YUM) beat the street estimates for 3Q EPS of $0.73 ahead of $0.71, driven by better SSS in China and lower than expected food costs. In a research report Jefferies & Company, Inc writes, "We find YUM attractive for its global growth opportunity, led by China and other...
-
Warner Chilcott Ltd Upgraded "The Deals & Earnings Keep Coming"
Monday, September 27, 2010 - 12:12pm | 94Warner Chilcott Ltd (NASDAQ: WCRX) upgrade to a BUY rating by Jefferies & Company, Inc. "We expect WCRX to continue to outperform" In a research report, Jefferies & Company Inc writes, "Last Friday Warner Chilcott Ltd announced it had amended it Enablex relationship with Novartis (NVS,CHF55...
-
Jefferies Still Bullish on Parametric Technology
Tuesday, June 8, 2010 - 9:09am | 111Jefferies analysts Ross MacMillan, Harish Parwani, and Sonya Banerjee remain optimistic on Parametric Technology (NASDAQ: PMTC). Management is confident as PMTC has grown amidst a recovering economy and higher demand for PLM software. Software licenses are expected to grow 35-40% in FY10 and 20%+...
-
Jefferies Deems IPCM Cured, Upgrades to Buy
Tuesday, June 8, 2010 - 8:59am | 134Jefferies & Company analysts Arthur I. Henderson, Brian Tanquilut, and Paxton Scott have upgraded IPC The Hospitalist Co. (NASDAQ: IPCM) to Buy. The analysts believe IPCM has been oversold, and is now valued too low relative to its growth rate. They expect "volumes to pick up in 2H10 as recent...
-
Jefferies Lowers Price Target on Emulex Corp.
Tuesday, June 8, 2010 - 8:41am | 104Jefferies analysts Munjal Shah, William Choi, and Rahul Khanwalkar maintained their Buy rating on Emulex Inc. (NYSE: ELX), but lowered their price target from $16 to $12. Yesterday, Emulex announced it would acquire its strategic partner ServerEngines for $184 million. This acquisition was somewhat...